Ann: RELINT: FPH: Disclosure of Director Relevant Interests

• Release Date: 09/06/14 15:44
• Summary: RELINT: FPH: Disclosure of Director Relevant Interests
• Price Sensitive: No
• Download Document  1.52KB

					FPH
09/06/2014 15:44
RELINT

REL: 1544 HRS Fisher & Paykel Healthcare Corporation Limited

RELINT: FPH: Disclosure of Director Relevant Interests

Name of director or officer of public issuer:  Michael Grenfell DANIELL
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable):  Not Applicable
Position held in public issuer:  Managing Director/Chief Executive Officer

B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities:   Ordinary shares and options to
acquire ordinary shares

C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities:   Beneficial Ownership
Name of registered holder of securities   Michael Grenfell DANIELL

D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition   4 June 2014
Consideration paid for acquisition   $Nil

If the relevant interest was disposed of--
Date of cancellation: 4 June 2014
Consideration received for cancellation:   $Nil

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acqusition or disposal took place:  Cancellation of 160,000 FPH options
and issue of 24,320 ordinary shares

E Total number of transactions this notice relates to:  One

F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer:   20 December 2013
End CA:00251353 For:FPH    Type:RELINT     Time:2014-06-09 15:44:40